|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Premium and service revenues | |||||
| Premium | |||||
| Service | |||||
| Total premium and service revenues | |||||
| Premium tax | |||||
| Total revenues | |||||
| Expenses: | |||||
| Medical costs | |||||
| Cost of services | |||||
| Selling, general and administrative expenses | |||||
| Depreciation expense | |||||
| Amortization of acquired intangible assets | |||||
| Premium tax expense | |||||
| Impairment | |||||
| Legal settlement | |||||
| Total operating expenses | |||||
| Earnings (loss) from operations | |||||
| Other income (expense): | |||||
| Investment and other income | |||||
| Debt extinguishment | |||||
| Interest expense | |||||
| Earnings (loss) before income tax | |||||
| Income tax (benefit) expense | |||||
| Net earnings (loss) | |||||
| Loss attributable to noncontrolling interests | |||||
| Net earnings (loss) attributable to Centene Corporation | |||||
| Net earnings (loss) per common share attributable to Centene Corporation: | |||||
| Basic earnings (loss) per common share (in usd per share) | |||||
| Diluted earnings (loss) per common share (in usd per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
